An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Experimental Drug Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting substances of uncertain source.
Several professionals said the popularity for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Service Reaction and Content Removal
According to TikTok, the service has taken down problematic content and prohibited related hashtags and query recommendations. The organization said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Online Trading Operations
Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.
After minutes of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.
Item Information and Costs
Inside these groups, posts show black plastic packages with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Measures
A representative for Telegram stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they can’t verify. Although the science behind retatrutide is valid, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially serious medical dangers”.
